CNS Drug: #CNSDOD
Notable Person: #BHCPOD
Phobia: #BNphobia
Term: #BHCTOD
National Conference Tweetchats
ABAI Annual Conference (5.25-29):
#abai2012
Dysfunctional changes in physiological functioning, psychological functioning, mood state, cognitive process, or all of these, as a consequence of consumption of [amphetamine-like drugs]; usually disruptive, and often stemming from central nervous system impairment.
Excerpts with permission from Graham, Allan W. & Schultz, Terry K. (Editors) (American Society of Addiction Medicine): Principles of Addiction Medicine
A. Recent use of amphetamine or a related substance (e.g., methylphenidate).
B. Clinically significant maladaptive behavioral or psychological changes (e.g.,euphoria or affective blunting; changes in sociability; hypervigilance; interpersonal sensitivity; anxiety, tension, or anger; stereotyped behaviors; impaired judgment; or impaired social or occupational functioning) that developed during, or shortly after, use of amphetamine or a related substance.
C. Two (or more) of the following, developing during, or shortly after, use of amphetamine or a related substance:
(1) tachycardia or bradycardia
(2) pupillary dilation
(3) elevated or lowered blood pressure
(4) perspiration or chills
(5) nausea or vomiting
(6) evidence of weight loss
(7) psychomotor agitation or retardation
(8) muscular weakness, respiratory depression, chest pain, or cardiac arrhythmias
(9) confusion, seizures, dyskinesias, dystonias, or coma
D. The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.
Specify if:
With Perceptual Disturbances
Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Copyright 2000 American Psychiatric Association
